Atlas Trials

Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy

Clinical trial NCT02446704 · UNKNOWN

Trial details

NCT number
NCT02446704
Sponsor
Zofia Piotrowska
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2015-10-13
Primary completion
2022-12-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.